| Title |
Non‐steroidal anti‐inflammatory drugs for low back pain
|
|---|---|
| Published in |
Cochrane database of systematic reviews, January 2008
|
| DOI | 10.1002/14651858.cd000396.pub3 |
| Pubmed ID | |
| Authors |
Pepijn DDM Roelofs, Rick A Deyo, Bart W Koes, Rob JPM Scholten, Maurits W van Tulder |
| Abstract |
Non-steroidal anti-inflammatory drugs (NSAIDs) are the most frequently prescribed medications worldwide and are widely used for patients with low-back pain. Selective COX-2 inhibitors are currently available and used for patients with low-back pain. |
X Demographics
The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 14% |
| France | 2 | 14% |
| Canada | 1 | 7% |
| Japan | 1 | 7% |
| Unknown | 8 | 57% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 12 | 86% |
| Practitioners (doctors, other healthcare professionals) | 2 | 14% |
Mendeley readers
The data shown below were compiled from readership statistics for 388 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 2 | <1% |
| Australia | 2 | <1% |
| United Kingdom | 2 | <1% |
| Chile | 1 | <1% |
| France | 1 | <1% |
| South Africa | 1 | <1% |
| Switzerland | 1 | <1% |
| United States | 1 | <1% |
| Lebanon | 1 | <1% |
| Other | 0 | 0% |
| Unknown | 376 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 63 | 16% |
| Student > Master | 49 | 13% |
| Student > Ph. D. Student | 42 | 11% |
| Researcher | 40 | 10% |
| Other | 35 | 9% |
| Other | 75 | 19% |
| Unknown | 84 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 165 | 43% |
| Nursing and Health Professions | 31 | 8% |
| Agricultural and Biological Sciences | 16 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 3% |
| Social Sciences | 11 | 3% |
| Other | 55 | 14% |
| Unknown | 98 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 70. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 March 2021.
All research outputs
#614,286
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#1,106
of 11,499 outputs
Outputs of similar age
#1,515
of 168,704 outputs
Outputs of similar age from Cochrane database of systematic reviews
#7
of 80 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 168,704 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 80 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.